iShares Nasdaq Biotechnology Index Fund ETF News

The World Health Day of 2020 puts these medical companies and the related stocks and ETFs in focus.

The World Health Day of 2020 puts these medical companies and the related stocks and ETFs in focus.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs April 6.) Forty Seven Inc (NASDAQ:...

US healthcare has been a perennial underperformer, lagging the S&P 500 for five years, and underperforming 10% last year. This is now changing. We think outperf

A U.S. District Court ruling found that Amarin’s patents for Vascepa were invalid due to obviousness; shares dropped 71%. Amarin will appeal; Some believe the d

If you want to grow your capital in this bear market, these 30 names should be on your radar right now.

Biotech stocks went along with the broader market flow in the week ended April 3, with the COVID-19 pandemic dictating sentiment. The week witnessed a host of clinical readouts...

DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main purchased a new stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) during the 4th quarter, according to its most recent

ValuEngine upgraded shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) from a sell rating to a hold rating in a research report sent to investors on Wednesday morning, ValuEngine reports. Shares

Over the last three weeks, the M2 money supply has exploded by a whopping $532 billion. Money supply is expanding at 26x the rate of QE1 during the 2008 financial crisis.

Fulton Bank N.A. lifted its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 2.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange

Casdin Capital’s Eli Casdin highlights seven promising life-sciences stocks, including bluebird bio, Invitae, and Crispr Therapeutics